Comparison of two techniques for evaluation of pancreatic islet viability: flow cytometry and FDA/PI staining

Authors

  • Natália Emerim Lemos Universidade Federal do Rio Grande do Sul. Hospital de Clínicas de Porto Alegre. https://orcid.org/0000-0002-0096-5801
  • Cristine Dieter Universidade Federal do Rio Grande do Sul. Hospital de Clínicas de Porto Alegre. https://orcid.org/0000-0003-2765-930X
  • Mariela Granero Farias Universidade Federal do Rio Grande do Sul. Hospital de Clínicas de Porto Alegre. https://orcid.org/0000-0002-4502-9312
  • Jakeline Rheinheimer Universidade Federal do Rio Grande do Sul. Hospital de Clínicas de Porto Alegre.
  • Bianca Marmontel de Souza Universidade Federal do Rio Grande do Sul. Hospital de Clínicas de Porto Alegre. https://orcid.org/0000-0001-8414-8878
  • Andrea Carla Bauer Universidade Federal do Rio Grande do Sul. Hospital de Clínicas de Porto Alegre. https://orcid.org/0000-0002-5041-4792
  • Daisy Crispim Moreira Universidade Federal do Rio Grande do Sul. Hospital de Clínicas de Porto Alegre. https://orcid.org/0000-0001-5095-9269

Keywords:

islet transplantation, islet isolation, viability, flow cytometry.

Abstract

Introduction: The success of islet transplantation for patients with unstable type 1 diabetes mellitus is dependent, in part, on the number of isolated islets as well as their quality, which is assessed by functional and viability tests. The currently employed test to evaluate islet viability, used by the Collaborative Islet Transplant Registry to release clinical islet product for transplantation, is the FDA/PI staining. However, the efficacy of this method is dependent on the researcher experience. In this context, a quantitative method may be useful. Therefore, the aim of this study was to compare islet viability assessed by flow cytometry and FDA/PI assay. Methods: Viability was evaluated in islets isolated from 10 male Wistar rats. Upon FDA and PI staining, 50 islets from each animal were analyzed under fluorescence microscope by two well-trained researchers. For flow cytometry, islets were dispersed, and then 100,000 single cells were incubated with 7AAD fluorophore (dyes necrotic and late apoptotic cells) and Annexin V-APC antibody (marker of early apoptotic cells). Results: A moderate correlation was found between the two techniques (r = 0.6; P= 0.047). The mean islet viability measured by flow cytometry was higher than the viability estimated using FDA/PI staining (95.5 ± 1.4% vs. 89.5 ± 5.0%; P= 0.002). Conclusions: Although flow cytometry is more expensive and time-consuming than FDA/PI staining, it is a quantitative technique, not dependent of the researcher experience. Thus, flow cytometry appears to be the technique of choice when aiming a more precise determination of islet viability.

Downloads

Download data is not yet available.

Downloads

Published

2021-12-08

How to Cite

1.
Lemos NE, Dieter C, Farias MG, Rheinheimer J, Souza BM de, Bauer AC, Moreira DC. Comparison of two techniques for evaluation of pancreatic islet viability: flow cytometry and FDA/PI staining. Clin Biomed Res [Internet]. 2021Dec.8 [cited 2022May22];41(4). Available from: https://seer.ufrgs.br/index.php/hcpa/article/view/108136

Issue

Section

Original Articles